Testing effectiveness (Phase 2)Active Not RecruitingNCT04166565
What this trial is testing
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
Who this might be right for
Multiple MyelomaExtramedullary Plasmacytoma
Stichting European Myeloma Network 41